Assura Plc (LON:AGR – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 48.11 and traded as low as GBX 46.76. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares changing hands.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on AGR. Shore Capital reissued a “hold” rating on shares of Assura in a research note on Wednesday, October 1st. Peel Hunt reiterated a “buy” rating and set a GBX 60 price objective on shares of Assura in a report on Tuesday, September 30th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of GBX 60.
Get Our Latest Research Report on Assura
Assura Stock Up 0.4%
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.
